BeOne Medicines Ltd. vs UCB SA
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- UCB SA is the larger company by market value: $48.6 B against $42.6 B for BeOne Medicines Ltd., 1.1 times as much (market caps of Aug 1, 2026). BeOne Medicines Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. UCB SA's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
- UCB SA had more revenue: $9.2 B in the year to December 2025 against $1.4 B for BeOne Medicines Ltd. in the year to December 2022.
- UCB SA made a net profit of $1.8 B, while BeOne Medicines Ltd. made a net loss of $2.0 B.
- UCB SA keeps more of each dollar of sales: a net margin of 20.1% against -141.6% for BeOne Medicines Ltd.
- BeOne Medicines Ltd. employs more people: 9,200 against 8,703 at UCB SA. Each employee brings in about $153,804 of revenue at BeOne Medicines Ltd. and $1,054,865 at UCB SA.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | BeOne Medicines Ltd. ONC · #608 in the world | UCB SA UCB.BR · #519 in the world |
|---|---|---|
| Profile | ||
| Country | 🇰🇾 Cayman Islands | 🇧🇪 Belgium |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | 2010 | 1928 |
| Size | ||
| Market cap | $42.6 B | $48.6 B |
| Revenue | $1.4 B | $9.2 B |
| Net income | $-2.0 B | $1.8 B▲ best |
| Employees | 9,200 | 8,703 |
| Valuation | ||
| P/E ratio | — | 26.3× |
| Price to sales | 30.1× | 5.3× |
| Price to book | 9.7× | 3.8× |
| Free cash flow yield | — | 2.3% |
| Profitability | ||
| Net margin | — | 20.1% |
| Return on equity | — | 15.2% |
| Growth | ||
| Revenue growth | — | 31.1% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Aug 2026 | Market cap Aug 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, BeOne Medicines Ltd. or UCB SA?
UCB SA is the larger company by market value: $48.6 B against $42.6 B for BeOne Medicines Ltd., 1.1 times as much (market caps of Aug 1, 2026). BeOne Medicines Ltd.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet. UCB SA's value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Which makes more money, BeOne Medicines Ltd. or UCB SA?
UCB SA had more revenue: $9.2 B in the year to December 2025 against $1.4 B for BeOne Medicines Ltd. in the year to December 2022. UCB SA made a net profit of $1.8 B, while BeOne Medicines Ltd. made a net loss of $2.0 B.
Which is more profitable, BeOne Medicines Ltd. or UCB SA?
UCB SA keeps more of each dollar of sales: a net margin of 20.1% against -141.6% for BeOne Medicines Ltd.
Which has more employees, BeOne Medicines Ltd. or UCB SA?
BeOne Medicines Ltd. employs more people: 9,200 against 8,703 at UCB SA. Each employee brings in about $153,804 of revenue at BeOne Medicines Ltd. and $1,054,865 at UCB SA.
More about BeOne Medicines Ltd.
More about UCB SA
Sources#
Every figure on this page comes from these, with the date shown next to it.